The Rescription Difference: A Clearer, Fairer Approach to Prescription Benefits

By Scott Martin, CEO of Rescription

For years, employers, brokers, and TPAs have been told that prescription drug pricing is inherently complex and that rising costs are unavoidable. Many have been led to believe that limited visibility is simply part of the system.

At Rescription, we reject that assumption.

Prescription benefits do not have to be confusing, conflicted, or unpredictable. The Rescription Difference is built on a simple principle: when pricing is clear and incentives are aligned, better outcomes follow for employers, consultants, and members alike.

Most traditional prescription benefit models rely on layers of hidden economics such as spread pricing, rebates, and administrative fees that are difficult to track and even harder to validate. These structures often reward higher drug prices rather than true cost control.

As a result, employers and their advisors are left managing one of the largest drivers of healthcare spend without a clear understanding of where their dollars are going. Cost savings can appear on paper, yet renewals remain volatile and trust erodes over time.

Rescription was built to eliminate that uncertainty.

We provide a single, transparent price for every drug. There are no rebates, no hidden markups, and no surprise fees. Employers, brokers, and TPAs all see the same pricing information, creating confidence and consistency across every stakeholder.

This level of clarity allows benefits professionals to evaluate prescription spend accurately, compare options fairly, and make decisions based on real economics rather than assumptions. Transparency, or what we call radical clarity at Rescription, is not an add on to our model. It is the foundation.

Many prescription benefit structures generate revenue when drug prices increase, which creates misalignment between vendors and plan sponsors. This misalignment often leads to painful renewals and unpredictable costs.

Rescription operates differently. We do not profit from spread pricing or rebate strategies. Our model is built around a clear, flat fee that aligns our success with lowering total drug spend over time.

By leveraging 340B pricing and international sourcing without hidden margins, we deliver meaningful savings directly to employers and members. When incentives are aligned, cost management becomes more sustainable and long-term planning becomes possible.

The prescription benefit landscape does not need incremental tweaks. It needs clarity, alignment, and trust.

The Rescription Difference is not about positioning against any single player. It is about offering a truly better and more transparent way forward for organizations that want visibility into their pharmacy spend and confidence in their benefit strategy.

If you are a broker, TPA, or employer ready to see how the Rescription Difference works in practice, we would welcome the conversation. Let’s talk.